Literature DB >> 10951274

Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ.

U Wieland1, S Jurk, S Weissenborn, T Krieg, H Pfister, A Ritzkowsky.   

Abstract

Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis, the prepuce, or the urethral meatus of elderly males. Up to 30% progress to squamous cell carcinoma. The cause of erythroplasia of Queyrat is largely unknown. Human papillomavirus type 16 DNA has previously been detected only in very few distinctly characterized patients. We have investigated 12 paraffin-embedded biopsies from eight patients with penile erythroplasia of Queyrat and control biopsies of inflammatory penile lesions, of genital Bowen's disease, and of premalignant/malignant cervical or vulvar lesions by 10 different polymerase chain reaction protocols for the presence of cutaneous and genital/mucosal human papillomaviruses. Human papillomavirus typing was performed by sequencing (cloned) polymerase chain reaction products. Human papillomavirus DNA was detected in all erythroplasia of Queyrat patients and in none of the controls with inflammatory penile lesions. The rare cutaneous carcinogenic epidermodysplasia verruciformis-associated human papillomavirus type 8 was present in all erythroplasia of Queyrat patients and the genital high-risk human papillomavirus type 16 in seven of eight patients (88%). In addition to human papillomavirus type 8 and human papillomavirus type 16, four patients carried the genital carcinogenic human papillomavirus type 39 and/or type 51. All human papillomavirus type 8 sequences found in erythroplasia of Queyrat showed some polymorphism among each other and differed in specific nucleotide exchanges from the human papillomavirus type 8 reference sequence. Viral load determinations (human papillomavirus copies/beta-globin gene copies) by realtime polymerase chain reactions showed that the human papillomavirus type 16 levels in the erythroplasia of Queyrat biopsies were one to five orders of magnitude higher than the human papillomavirus type 8 levels. Human papillomavirus type 8 was not detected in cervical or vulvar precancerous and cancerous lesions and in Bowen's disease lesions that carried genital human papillomavirus types. The data suggest that in erythroplasia of Queyrat, in contrast to other genital neoplasias, a coinfection with human papillomavirus type 8 and carcinogenic genital human papillomavirus types occurs. The presence or absence of human papillomavirus type 8 might help to distinguish between penile erythroplasia of Queyrat and Bowen's diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951274     DOI: 10.1046/j.1523-1747.2000.00069.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.

Authors:  Staci L Sudenga; Donna J Ingles; Christine M Pierce Campbell; Hui-Yi Lin; William J Fulp; Jane L Messina; Mark H Stoler; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Eur Urol       Date:  2015-06-06       Impact factor: 20.096

2.  Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States.

Authors:  Staci L Sudenga; B Nelson Torres; Roberto Silva; Luisa L Villa; Eduardo Lazcano-Ponce; Martha Abrahamsen; Maria Luiza Baggio; Jorge Salmeron; Manuel Quiterio; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-26       Impact factor: 4.254

3.  A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision.

Authors:  Jee Woong Choi; Mira Choi; Kwang Hyun Cho
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

4.  Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Authors:  Staci L Sudenga; B Nelson Torres; William J Fulp; Roberto Silva; Luisa L Villa; Eduardo Lazcano-Ponce; Donna J Ingles; Mark Stoler; Jane L Messina; Martha Abrahamsen; Maria Luiza Baggio; Jorge Salmeron; Manuel Quiterio; Anna R Giuliano
Journal:  Int J Cancer       Date:  2016-10-20       Impact factor: 7.396

Review 5.  Genital HPV infection and related lesions in men.

Authors:  Gabriella M Anic; Anna R Giuliano
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

6.  Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study.

Authors:  Shams Rahman; Christine M Pierce Campbell; Tim Waterboer; Dana E Rollison; Donna J Ingles; B Nelson Torres; Angelika Michel; Staci L Sudenga; Michael Pawlita; Luisa L Villa; Eduardo Lazcano Ponce; Amy R Borenstein; Wei Wang; Anna R Giuliano
Journal:  J Gen Virol       Date:  2016-10-06       Impact factor: 3.891

7.  Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study.

Authors:  Christine M Pierce Campbell; Jane L Messina; Mark H Stoler; Drazen M Jukic; Massimo Tommasino; Tarik Gheit; Dana E Rollison; Laura Sichero; Bradley A Sirak; Donna J Ingles; Martha Abrahamsen; Beibei Lu; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  J Clin Virol       Date:  2013-10-16       Impact factor: 3.168

8.  Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts.

Authors:  G Gross; H Pfister
Journal:  Med Microbiol Immunol       Date:  2003-06-28       Impact factor: 3.402

9.  Human papillomavirus associated with oesophageal cancer.

Authors:  T Matsha; R Erasmus; A B Kafuko; D Mugwanya; A Stepien; M I Parker
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

10.  Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients.

Authors:  Wei Li; Carol H Thompson; Ding Xin; Yvonne E Cossart; Christopher J O'Brien; Edward B McNeil; Kan Gao; Richard A Scolyer; Barbara R Rose
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.